| RS2147419969 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147419990 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147421854 |
ZC4H2
|
Health Risk |
Pathogenic |
— |
| RS2147423955 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147424002 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS2147424169 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147424186 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147424879 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147424988 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147425053 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147425059 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147425786 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147425836 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147425882 |
TANC2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autistic features and language delay, with or without seizures |
| RS2147427209 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147427255 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147427470 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147427505 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147427562 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147427580 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147427904 |
TANC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with autistic features and language delay, with or without seizures |
| RS2147428155 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147428293 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147429006 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147429013 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147429591 |
OPHN1
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS2147429777 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, Thyroid cancer |
| RS2147429797 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147429812 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS2147429948 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147429973 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147430161 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147430166 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147430256 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147431016 |
BTK
|
Health Risk |
Likely pathogenic |
— |
| RS2147431031 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147431970 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147432469 |
OPHN1
|
Health Risk |
Likely pathogenic |
— |
| RS2147432826 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2147433246 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147434002 |
FGD1
|
Health Risk |
Likely pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2147434008 |
FGD1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2147434341 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147435100 |
FGD1
|
Health Risk |
Pathogenic |
— |
| RS2147435832 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147435884 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147436154 |
FGD1
|
Health Risk |
Pathogenic |
— |
| RS2147436223 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2147436378 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147436590 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2147436623 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147436658 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147436755 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2147437405 |
ACSL4
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 63 |
| RS2147439176 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147439257 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147439364 |
NEXMIF
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS2147439375 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS2147439499 |
NEXMIF
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS2147439516 |
NEXMIF
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS2147439558 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147439567 |
NEXMIF
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS2147439776 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147439880 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS2147439932 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147439956 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440006 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS2147440054 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440078 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440148 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440160 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147440346 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440462 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440618 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440709 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440717 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS2147440783 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440933 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147440953 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147441019 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147441024 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147441229 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147441259 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147441295 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147441408 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS2147441502 |
NEXMIF
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2147441539 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS2147442619 |
NEXMIF
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS2147443380 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147444867 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147444958 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147445599 |
FANCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group B |
| RS2147445909 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147445956 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147447393 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147447513 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147447605 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147447737 |
CELSR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mild to moderate NDD, Mild to moderate NDD |
| RS2147447747 |
MBTPS2
|
Health Risk |
Pathogenic |
— |
| RS2147448022 |
COL4A5
|
Health Risk |
Pathogenic |
— |